|
시장보고서
상품코드
2084712
경비 약물전달법 시장 : 치료 용도별, 제형별, 용기 종류별, 시스템 종류별, 최종사용자별, 유통 채널별, 지역별Nasal Drug Delivery Mode Market, By Therapeutic Application, By Dosage Form, By Container Type, By System Type, By End Users, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
경비 약물전달법 시장은 2026년에 676억 달러 규모에 달할 것으로 추정되며, 2033년까지 1,003억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 5.8%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 676억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 5.80% | 예측 금액(2033년) | 1,003억 달러 |
약물전달이란, 약물을 목표 부위로 전달하여 방출 및 흡수를 유도하기 위해 이용되는 기술을 말합니다. 비강을 통한 약물전달에서는(국소적 또는 전신적인) 치료 효과가 신속하게 나타납니다. 국소용 충혈 완화제나 항염증제를 비강 내에 투여하는 것은 가장 일반적인 국소 비강 약물전달 방법입니다. 비강 및 부비동 질환의 치료에 있어서는 비강 투여가 합리적인 선택이 됩니다. 오랜 기간 동안 비강 투여 경로는 경구 및 비경구 약물전달을 대체할 유망한 대안으로 널리 주목받아 왔습니다.
시장 역학
천식 및 만성 폐쇄성 폐질환(COPD) 유병률의 증가, 자가 투여 관행의 확산, 그리고 비강 약물전달에 대한 선호도 증가는 예측 기간 동안 전 세계 비강 약물전달 방식 시장을 견인할 것으로 예상되는 주요 요인 중 일부입니다. 천식은 소아와 성인 모두에게 영향을 미치는 주요 비전염성 질환(NCD)입니다. 예를 들어, 미국 천식·알레르기 재단(AAFA)에 따르면, 미국에서는 2,500만 명 이상, 즉 약 13명 중 1명이 천식을 앓고 있습니다. 또한, 미국에서는 18세 이상의 성인 중 2,000만 명 이상이 천식을 앓고 있으며, 천식 유병률은 미국 흑인 성인에서 가장 높습니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 분석도 제공하고 있습니다.
- 전 세계 경비 약물전달법 시장 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 경비 약물전달법 시장 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 경비 약물전달법 시장 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 경비 약물전달법 시장 : 치료 용도별(2021-2033년)
제5장 세계의 경비 약물전달법 시장 : 제형별(2021-2033년)
제6장 세계의 경비 약물전달법 시장 : 용기 종류별(2021-2033년)
제7장 세계의 경비 약물전달법 시장 : 시스템 종류별(2021-2033년)
제8장 세계의 경비 약물전달법 시장 : 최종사용자별(2021-2033년)
제9장 세계의 경비 약물전달법 시장 : 유통 채널별(2021-2033년)
제10장 세계의 경비 약물전달법 시장 : 지역별(2021-2033년)
제11장 경쟁 구도
제12장 섹션
KSM 26.07.16Nasal Drug Delivery Mode Market is estimated to be valued at USD 67.6 Bn in 2026 and is expected to reach USD 100.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 67.6 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.80% | 2033 Value Projection: | USD 100.3 Bn |
Drug delivery refers to the technology utilized to present the drug to the desired body site for drug release and absorption. Intranasal drug delivery offers a rapid onset of therapeutic effects (local or systemic). Nasal applications of topical decongestants or anti-inflammatory drugs are most popular topical nasal drug deliveries. Nasal delivery is the logical choice for treatment of diseases in the nose and paranasal sinuses. Over the years, nasal route has gained widespread interest as a promising and an alternative route to oral and parenteral drug delivery.
Market Dynamics
Growing prevalence of asthma and chronic obstructive pulmonary disease (COPD), increasing adoption of self-administration practices, and increasing preference for nasal drug delivery are some major factors expected to boost the growth of the global nasal drug delivery mode market over the forecast period. Asthma is a major noncommunicable disease (NCD) that affects both children and adults. For instance, according to the Asthma and Allergy Foundation of America (AAFA), more than 25 million people in the U.S. have asthma, about 1 in 13 people. Moreover, over 20 million adults aged 18 and older have asthma in the U.S., and asthma rates are highest in Black adults in the United States.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the nasal drug delivery mode market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Merck & Co., Inc., Astra Zeneca, GlaxoSmithKline Plc, Mystic Pharmaceuticals, PendoPharm Inc., Bausch Health, 3M, Cadila Pharmaceuticals, Optinose, Dr. Reddy Laboratories, Neurelis Inc., Aptar Group, Johnson & Johnson Services Inc., ENT Technologies Pty Ltd., and Becton, Dickinson and Company, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global nasal drug delivery mode market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal drug delivery mode market.
Market Segmentation
- By Therapeutic Application (Revenue, USD Bn, 2021-2033)
- Asthma
- Rhinitis
- Others
- By Dosage Form (Revenue, USD Bn, 2021-2033)
- Powder
- Spray
- Gel
- By Container Type (Revenue, USD Bn, 2021-2033)
- Pressurized Container
- Non Pressurized
- Container
- By System Type (Revenue, USD Bn, 2021-2033)
- Multi- Dose
- Bi-Dose
- Unit Dose
- By End Users (Revenue, USD Bn, 2021-2033)
- Hospitals
- Homecare Settings
- By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Merck & Co., Inc.
- AstraZeneca
- GlaxoSmithKline plc (GSK)
- Mystic Pharmaceuticals
- Johnson & Johnson Services Inc.
- PendoPharm Inc.
- Bausch Health Companies Inc.
- 3M Company
- Cadila Pharmaceuticals Ltd.
- OptiNose Inc.
- Reddy's Laboratories Ltd.
- ENT Technologies Pty Ltd.
- Neurelis Inc.
- AptarGroup, Inc.
- Becton, Dickinson and Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Therapeutic Application
- Market Snapshot, By Dosage Form
- Market Snapshot, By Container Type
- Market Snapshot, By System Type
- Market Snapshot, By End Users
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Global Nasal Drug Delivery Mode Market, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Nasal Drug Delivery Mode Market, By Dosage Form, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Spray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Nasal Drug Delivery Mode Market, By Container Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pressurized Container
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Non Pressurized
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Container
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Nasal Drug Delivery Mode Market, By System Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Multi- Dose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bi-Dose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Unit Dose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Nasal Drug Delivery Mode Market, By End Users, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Nasal Drug Delivery Mode Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
10. Global Nasal Drug Delivery Mode Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- GlaxoSmithKline plc (GSK)
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Mystic Pharmaceuticals
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Johnson & Johnson Services Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- PendoPharm Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- 3M Company
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Cadila Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- OptiNose Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Dr. Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- ENT Technologies Pty Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Neurelis Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- AptarGroup, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Merck & Co., Inc.
- Analyst Views
12. Section
- References
- Research Methodology
- About Us
